Add Blood Glucose Monitors: what Factors Affect Accuracy?

Blood-Glucose-Monitors%3A-what-Factors-Affect-Accuracy%3F.md

@@ -0,0 +1,7 @@
+<br>When used correctly, blood glucose monitors - small devices that measure and display your blood sugar level - are usually accurate. But occasionally they may be incorrect. Test using a control solution. Follow your typical blood-testing procedure, but use a liquid control solution instead of [GlycoMode Blood Sugar](http://pghpedia.com/index.php/Pioglitazone_15_MG_Tablet). These solutions usually come with your monitor and are available at most drugstores and pharmacies. Use liquid control solutions every time you open a new container of test strips, and then use the solutions occasionally as you use the strips. You generally should also use liquid control solutions if you drop your blood glucose meter, or whenever you get unusual results. Match your reading with lab results. Take the blood glucose monitor along when you visit your health care provider or have an [appointment](https://data.gov.uk/data/search?q=appointment) for lab work. Check your blood sugar level with your meter at the same time that blood is drawn for lab tests, being sure to use a fingerstick sample, not blood from the blood draw. Then compare your meter's reading with the lab results. Results that are within 15% of the lab reading are considered accurate.<br>
+
+<br>If you are evaluating what organic allulose is and how it works, the next question is inevitable: what does it actually do inside the body? Sweetness without consequence sounds appealing, but formulators, healthcare professionals, and informed consumers want evidence - not marketing language. This article walks through the current scientific understanding of allulose and its effects on blood sugar, insulin, calorie intake, kidney function, liver metabolism, gut tolerance, and long-term safety. Every claim here traces back to published research or regulatory determinations. Allulose has a glycemic index of approximately zero. It does not raise blood glucose and does not trigger a meaningful insulin response. This is not a marginal effect - it is a consistent finding across clinical trials. A double-blind crossover study published in the Journal of Nutritional Science and Vitaminology demonstrated that 5 g of allulose consumed with a meal significantly reduced postprandial blood glucose elevation compared to the same meal without allulose.<br>
+
+<br>The mechanism appears to involve GLP-1 (glucagon-like peptide-1) stimulation: allulose encourages the release of this incretin hormone, which in turn slows gastric emptying and enhances insulin sensitivity. For food formulators, this means organic allulose sweetener can serve a functional role beyond sweetness - it actively helps blunt the glycemic impact of other carbohydrates in a formulation. For diabetic-friendly product claims, this is a meaningful differentiator. It is worth emphasizing that allulose does not lower blood sugar below normal levels. It moderates the spike. The effect is stabilizing, not hypoglycemic. Sugar delivers roughly 4 kcal per gram. Allulose delivers approximately 0.4 kcal per gram - about 90% fewer calories. The reason is straightforward: the human body largely cannot metabolize it. Unlike glucose, which is readily absorbed and oxidized for energy, allulose passes through metabolic pathways inefficiently. Most of what is absorbed is filtered by the kidneys and excreted in urine within 24 to 48 hours.<br>
+
+<br>The small fraction that does undergo metabolism produces minimal caloric yield. This caloric profile has regulatory backing. The FDA permits allulose to be excluded from "Total Sugars" and "Added Sugars" declarations on Nutrition Facts labels (more on labeling nuances below). For product developers targeting calorie reduction without sacrificing mouthfeel or browning, this is one of the few options that works. A common concern - especially among consumers with kidney conditions - is whether a substance primarily excreted through urine places stress on renal function. Multiple toxicology studies, including a 90-day subchronic study and a two-year chronic toxicity study in rats, found no nephrotoxicity at doses far exceeding typical human consumption. Human clinical trials monitoring renal biomarkers (creatinine, BUN, eGFR) have similarly reported no adverse changes. The key distinction is between excretion through the kidneys and damage to the kidneys. Allulose is a small, water-soluble molecule that the kidneys filter efficiently - much like certain vitamins and electrolytes. Efficient filtration is not the same as toxic burden.<br>